US 11351183
Use of thyroid beta-agonists
granted A61KA61K31/662A61K31/665
Quick answer
US patent 11351183 (Use of thyroid beta-agonists) held by Viking Therapeutics, Inc. expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Viking Therapeutics, Inc.
- Grant date
- Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/662, A61K31/665, A61P, A61P25/00